Healthcare >> CEO Interviews >> August 10, 2009

Senomyx, Inc. – Kent Snyder (snmx)

KENT SNYDER is President, Chief Executive Officer and Chairman of the Board of Directors of Senomyx, Inc. Prior to joining Senomyx in June 2003, he held various marketing and sales management positions with Agouron Pharmaceuticals, Inc., a Pfizer company. Mr. Snyder was President of Global Commercial Operations at Agouron after having served as Senior Vice President of Commercial Affairs and Vice President of Business Development. Mr. Snyder is a director of Santarus, Inc., a publicly held biopharmaceutical company, and VentiRx Pharmaceuticals, Inc., a privately held biopharmaceutical company. Mr. Snyder received his B.S. from the University of Kansas and his MBA from Rockhurst College. Profile
TWST: Could you give a brief history of your company and discuss what your focus

is on now?

Mr. Snyder: The company was founded in 1998 by two professors at the University

of California, San